Copyright Reports & Markets. All rights reserved.

Global Gene Therapy Viral Packaging Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Gene Therapy Viral Packaging Service by Type
    • 1.3.1 Overview: Global Gene Therapy Viral Packaging Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Gene Therapy Viral Packaging Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Adeno-Associated Virus Packaging
    • 1.3.4 Lentiviral Packaging
    • 1.3.5 Adenovirus Packaging
    • 1.3.6 Other
  • 1.4 Global Gene Therapy Viral Packaging Service Market by Application
    • 1.4.1 Overview: Global Gene Therapy Viral Packaging Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Gene Therapy
    • 1.4.3 Scientific Research
  • 1.5 Global Gene Therapy Viral Packaging Service Market Size & Forecast
  • 1.6 Global Gene Therapy Viral Packaging Service Market Size and Forecast by Region
    • 1.6.1 Global Gene Therapy Viral Packaging Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Gene Therapy Viral Packaging Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Packgene
    • 2.1.1 Packgene Details
    • 2.1.2 Packgene Major Business
    • 2.1.3 Packgene Gene Therapy Viral Packaging Service Product and Solutions
    • 2.1.4 Packgene Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Packgene Recent Developments and Future Plans
  • 2.2 VectorBuilder
    • 2.2.1 VectorBuilder Details
    • 2.2.2 VectorBuilder Major Business
    • 2.2.3 VectorBuilder Gene Therapy Viral Packaging Service Product and Solutions
    • 2.2.4 VectorBuilder Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 VectorBuilder Recent Developments and Future Plans
  • 2.3 Ubigene
    • 2.3.1 Ubigene Details
    • 2.3.2 Ubigene Major Business
    • 2.3.3 Ubigene Gene Therapy Viral Packaging Service Product and Solutions
    • 2.3.4 Ubigene Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Ubigene Recent Developments and Future Plans
  • 2.4 GenScript
    • 2.4.1 GenScript Details
    • 2.4.2 GenScript Major Business
    • 2.4.3 GenScript Gene Therapy Viral Packaging Service Product and Solutions
    • 2.4.4 GenScript Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GenScript Recent Developments and Future Plans
  • 2.5 Abace Biology
    • 2.5.1 Abace Biology Details
    • 2.5.2 Abace Biology Major Business
    • 2.5.3 Abace Biology Gene Therapy Viral Packaging Service Product and Solutions
    • 2.5.4 Abace Biology Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abace Biology Recent Developments and Future Plans
  • 2.6 Genecfps
    • 2.6.1 Genecfps Details
    • 2.6.2 Genecfps Major Business
    • 2.6.3 Genecfps Gene Therapy Viral Packaging Service Product and Solutions
    • 2.6.4 Genecfps Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Genecfps Recent Developments and Future Plans
  • 2.7 GENEWIZ
    • 2.7.1 GENEWIZ Details
    • 2.7.2 GENEWIZ Major Business
    • 2.7.3 GENEWIZ Gene Therapy Viral Packaging Service Product and Solutions
    • 2.7.4 GENEWIZ Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GENEWIZ Recent Developments and Future Plans
  • 2.8 Obio Technology
    • 2.8.1 Obio Technology Details
    • 2.8.2 Obio Technology Major Business
    • 2.8.3 Obio Technology Gene Therapy Viral Packaging Service Product and Solutions
    • 2.8.4 Obio Technology Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Obio Technology Recent Developments and Future Plans
  • 2.9 Charles River Laboratories
    • 2.9.1 Charles River Laboratories Details
    • 2.9.2 Charles River Laboratories Major Business
    • 2.9.3 Charles River Laboratories Gene Therapy Viral Packaging Service Product and Solutions
    • 2.9.4 Charles River Laboratories Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.10 Takara Bio
    • 2.10.1 Takara Bio Details
    • 2.10.2 Takara Bio Major Business
    • 2.10.3 Takara Bio Gene Therapy Viral Packaging Service Product and Solutions
    • 2.10.4 Takara Bio Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Takara Bio Recent Developments and Future Plans
  • 2.11 abm
    • 2.11.1 abm Details
    • 2.11.2 abm Major Business
    • 2.11.3 abm Gene Therapy Viral Packaging Service Product and Solutions
    • 2.11.4 abm Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 abm Recent Developments and Future Plans
  • 2.12 Cell Biolabs
    • 2.12.1 Cell Biolabs Details
    • 2.12.2 Cell Biolabs Major Business
    • 2.12.3 Cell Biolabs Gene Therapy Viral Packaging Service Product and Solutions
    • 2.12.4 Cell Biolabs Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Cell Biolabs Recent Developments and Future Plans
  • 2.13 Cyagen
    • 2.13.1 Cyagen Details
    • 2.13.2 Cyagen Major Business
    • 2.13.3 Cyagen Gene Therapy Viral Packaging Service Product and Solutions
    • 2.13.4 Cyagen Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Cyagen Recent Developments and Future Plans
  • 2.14 Vector Biolabs
    • 2.14.1 Vector Biolabs Details
    • 2.14.2 Vector Biolabs Major Business
    • 2.14.3 Vector Biolabs Gene Therapy Viral Packaging Service Product and Solutions
    • 2.14.4 Vector Biolabs Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Vector Biolabs Recent Developments and Future Plans
  • 2.15 Lonza
    • 2.15.1 Lonza Details
    • 2.15.2 Lonza Major Business
    • 2.15.3 Lonza Gene Therapy Viral Packaging Service Product and Solutions
    • 2.15.4 Lonza Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Lonza Recent Developments and Future Plans
  • 2.16 Oxford BioMedica
    • 2.16.1 Oxford BioMedica Details
    • 2.16.2 Oxford BioMedica Major Business
    • 2.16.3 Oxford BioMedica Gene Therapy Viral Packaging Service Product and Solutions
    • 2.16.4 Oxford BioMedica Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Oxford BioMedica Recent Developments and Future Plans
  • 2.17 Catalent
    • 2.17.1 Catalent Details
    • 2.17.2 Catalent Major Business
    • 2.17.3 Catalent Gene Therapy Viral Packaging Service Product and Solutions
    • 2.17.4 Catalent Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Catalent Recent Developments and Future Plans
  • 2.18 Wuxi Shengji Pharmaceuticals
    • 2.18.1 Wuxi Shengji Pharmaceuticals Details
    • 2.18.2 Wuxi Shengji Pharmaceuticals Major Business
    • 2.18.3 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Product and Solutions
    • 2.18.4 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Wuxi Shengji Pharmaceuticals Recent Developments and Future Plans
  • 2.19 Boten Biotech
    • 2.19.1 Boten Biotech Details
    • 2.19.2 Boten Biotech Major Business
    • 2.19.3 Boten Biotech Gene Therapy Viral Packaging Service Product and Solutions
    • 2.19.4 Boten Biotech Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Boten Biotech Recent Developments and Future Plans
  • 2.20 Cytiva
    • 2.20.1 Cytiva Details
    • 2.20.2 Cytiva Major Business
    • 2.20.3 Cytiva Gene Therapy Viral Packaging Service Product and Solutions
    • 2.20.4 Cytiva Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Cytiva Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Gene Therapy Viral Packaging Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Gene Therapy Viral Packaging Service by Company Revenue
    • 3.2.2 Top 3 Gene Therapy Viral Packaging Service Players Market Share in 2025
    • 3.2.3 Top 6 Gene Therapy Viral Packaging Service Players Market Share in 2025
  • 3.3 Gene Therapy Viral Packaging Service Market: Overall Company Footprint Analysis
    • 3.3.1 Gene Therapy Viral Packaging Service Market: Region Footprint
    • 3.3.2 Gene Therapy Viral Packaging Service Market: Company Product Type Footprint
    • 3.3.3 Gene Therapy Viral Packaging Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Gene Therapy Viral Packaging Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Gene Therapy Viral Packaging Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Gene Therapy Viral Packaging Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Gene Therapy Viral Packaging Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
  • 6.2 North America Gene Therapy Viral Packaging Service Market Size by Application (2021-2032)
  • 6.3 North America Gene Therapy Viral Packaging Service Market Size by Country
    • 6.3.1 North America Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Gene Therapy Viral Packaging Service Market Size by Country
    • 7.3.1 Europe Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Gene Therapy Viral Packaging Service Market Size by Region
    • 8.3.1 Asia-Pacific Gene Therapy Viral Packaging Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
  • 9.2 South America Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
  • 9.3 South America Gene Therapy Viral Packaging Service Market Size by Country
    • 9.3.1 South America Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country
    • 10.3.1 Middle East & Africa Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Gene Therapy Viral Packaging Service Market Drivers
  • 11.2 Gene Therapy Viral Packaging Service Market Restraints
  • 11.3 Gene Therapy Viral Packaging Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Gene Therapy Viral Packaging Service Industry Chain
  • 12.2 Gene Therapy Viral Packaging Service Upstream Analysis
  • 12.3 Gene Therapy Viral Packaging Service Midstream Analysis
  • 12.4 Gene Therapy Viral Packaging Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Gene Therapy Viral Packaging Service market size was valued at US$ 2593 million in 2025 and is forecast to a readjusted size of US$ 5426 million by 2032 with a CAGR of 11.2% during review period.
    A specialized biotechnology service for packaging target gene vectors into viral particles suitable for gene therapy applications. This service typically includes plasmid design and preparation, viral particle generation, purification, and quality control. Common viral packaging types include adeno-associated virus (AAV), adenovirus (AdV), and lentivirus (LV). It is widely used in gene function studies, disease model development, and preclinical and clinical research in gene therapy.
    This report is a detailed and comprehensive analysis for global Gene Therapy Viral Packaging Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Gene Therapy Viral Packaging Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Gene Therapy Viral Packaging Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Gene Therapy Viral Packaging Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Gene Therapy Viral Packaging Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Gene Therapy Viral Packaging Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Gene Therapy Viral Packaging Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Packgene, VectorBuilder, Ubigene, GenScript, Abace Biology, Genecfps, GENEWIZ, Obio Technology, Charles River Laboratories, Takara Bio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Gene Therapy Viral Packaging Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Adeno-Associated Virus Packaging
    Lentiviral Packaging
    Adenovirus Packaging
    Other
    Market segment by Application
    Gene Therapy
    Scientific Research
    Market segment by players, this report covers
    Packgene
    VectorBuilder
    Ubigene
    GenScript
    Abace Biology
    Genecfps
    GENEWIZ
    Obio Technology
    Charles River Laboratories
    Takara Bio
    abm
    Cell Biolabs
    Cyagen
    Vector Biolabs
    Lonza
    Oxford BioMedica
    Catalent
    Wuxi Shengji Pharmaceuticals
    Boten Biotech
    Cytiva
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Gene Therapy Viral Packaging Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Gene Therapy Viral Packaging Service, with revenue, gross margin, and global market share of Gene Therapy Viral Packaging Service from 2021 to 2026.
    Chapter 3, the Gene Therapy Viral Packaging Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Gene Therapy Viral Packaging Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy Viral Packaging Service.
    Chapter 13, to describe Gene Therapy Viral Packaging Service research findings and conclusion.

    Buy now